NCT01424462View on ClinicalTrials.gov

Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 19, 2010

Primary Completion Date

July 6, 2010

Study Completion Date

July 6, 2010

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

A

Single dose treatment IR formulation

DRUG

B

Low Extended release single dose

DRUG

C

Medium extended release formulation

DRUG

D

High extended release rate single dose

Trial Locations (1)

2031

GSK Investigational Site, Randwick

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01424462 - Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place. | Biotech Hunter | Biotech Hunter